Select Medical (NYSE:SEM) Earns Buy Rating from Benchmark

Benchmark reiterated their buy rating on shares of Select Medical (NYSE:SEM) in a research report sent to investors on Friday, Benzinga reports. The brokerage currently has a $48.00 target price on the health services provider’s stock.

Separately, Royal Bank of Canada increased their target price on Select Medical from $36.00 to $40.00 and gave the stock an outperform rating in a research report on Monday, May 6th. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of Moderate Buy and an average target price of $36.50.

Select Medical Price Performance

SEM stock traded up $0.35 on Friday, reaching $32.91. The company had a trading volume of 331,700 shares, compared to its average volume of 624,744. Select Medical has a 1 year low of $21.28 and a 1 year high of $40.50. The company has a debt-to-equity ratio of 2.30, a quick ratio of 1.22 and a current ratio of 1.22. The company’s fifty day moving average is $35.77 and its 200 day moving average is $31.20. The company has a market cap of $4.28 billion, a P/E ratio of 15.50, a PEG ratio of 1.55 and a beta of 1.43.

Select Medical (NYSE:SEM) last issued its quarterly earnings results on Thursday, August 1st. The health services provider reported $0.60 earnings per share for the quarter, missing analysts’ consensus estimates of $0.61 by ($0.01). Select Medical had a return on equity of 17.88% and a net margin of 3.91%. The business had revenue of $1.76 billion for the quarter, compared to analysts’ expectations of $1.74 billion. During the same period in the prior year, the company earned $0.61 EPS. The company’s revenue for the quarter was up 5.1% compared to the same quarter last year. On average, research analysts forecast that Select Medical will post 2.19 earnings per share for the current year.

Select Medical Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, August 30th. Investors of record on Wednesday, August 14th will be issued a $0.125 dividend. The ex-dividend date of this dividend is Wednesday, August 14th. This represents a $0.50 annualized dividend and a yield of 1.52%. Select Medical’s dividend payout ratio is currently 23.81%.

Institutional Trading of Select Medical

Several large investors have recently added to or reduced their stakes in SEM. Hexagon Capital Partners LLC increased its holdings in Select Medical by 528.7% in the 2nd quarter. Hexagon Capital Partners LLC now owns 767 shares of the health services provider’s stock valued at $27,000 after purchasing an additional 645 shares in the last quarter. GAMMA Investing LLC purchased a new stake in shares of Select Medical during the fourth quarter worth about $33,000. Transcendent Capital Group LLC acquired a new position in shares of Select Medical in the second quarter worth about $35,000. Fidelis Capital Partners LLC acquired a new stake in Select Medical during the 1st quarter valued at approximately $47,000. Finally, Innealta Capital LLC acquired a new stake in shares of Select Medical during the second quarter worth approximately $117,000. 89.48% of the stock is currently owned by institutional investors and hedge funds.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.